Beken Bio
UEI: LJJ9XNCRE9L7
• CAGE: 8QSG4
Overview
Awardee Type
Parent
Company Description
Beken Bio develops liquid biopsies that help diagnose cancer at its earliest stage using our patent-pending 3D REVEAL.
Name
Beken Bio
Website
Headquarters
San Diego, CA
United States
United States
Most Recent Award
Aug. 15, 2024
Calculating
Federal grant recipient
BEKEN BIO, INC.
(UEI LJJ9XNCRE9L7, CAGE 8QSG4)
is headquartered in San Diego CA.
Its primary registered NAICS is 541714 Research and Development in Biotechnology (except Nanobiotechnology).
The corporation
was founded in July 2020 and
federally registered in
August 2020.
Federal Award Analysis
Beken Bio federal award history
$-
Contracts
$-
Subcontracts
$-
Grants
$-
Subgrants
$-
Total
No Results
Calculating
Calculating
No Results
Calculating
Calculating
No Results
Calculating
Calculating
| Year | Contracts | Subcontracts | Grants | Subgrants |
|---|
No Results
Calculating
Calculating
No Results
Calculating
Calculating
Federal Registration and Certifications
Legal Name
BEKEN BIO, INC.
Division Name
BEKEN BIO
UEI
LJJ9XNCRE9L7
CAGE Code
8QSG4
SBA Certifications
None
Self Certifications
None
Entity Structure
Corporate Entity (Not Tax Exempt)
Purpose of Registration
Federal Contracts and Assistance
Date Founded
July 7, 2020
Initial Registration
Aug. 12, 2020
Last Registration
Jan. 2, 2025
Registration Activation
Dec. 18, 2024
Registration Expiration
Dec. 16, 2025
Fiscal Year End
December 31
Reported Entity Types
For Profit Organization
State of Incorporation
DE
Country of Incorporation
USA
Employees
<500
Reported NAICS
Accepts Credit Cards
No